A Meeting Regarding the Therapeutic Potential of Antibodies for HIV
In 2009 Search was introduced to an interesting monoclonal antibody that had been used in a 188 patients in the early days of the disease before the antivirals existed that showed promissing evidence of viral reduction. The antibody is called Cytolin. Since then we have been following the progress of its development as it is now being researched by Dr. Eric Rosenberg at Massachusetts General Hospital. We conducted an interview with Dr. Rosenberg about its progress in October of 2011 which you can read under our Q&A section here. To our surprise in the last few years there has been an explosion of antibodies being approved as therapeutics for all kinds of illnesses, and there are now multiple promising ones in the lab with potential for the HIV population including Ibalizumab, Cytolin, and PRO140.